AGEN
Price:
$4.95
Market Cap:
$106.78M
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs comprising Prophage vaccine candidate; and QS-21 Stimulon adjuvant, a saponin-based vaccine adjuvant. The company also develops Balstilimab, an anti-PD-1 antagonist that has completed Phase II clinical trial to treat second line cervical cancer; AGEN1181, an anti-CTLA-4 monospecific antibody that is in Phase 1/2 clinical trial; AGEN2373, an anti-CD137 m...[Read more]
Industry
Biotechnology
IPO Date
2000-02-08
Stock Exchange
NASDAQ
Ticker
AGEN
According to Agenus Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.37. This represents a change of -11.90% compared to the average of 0.42 of the last 4 quarters.
The mean historical Current Ratio of Agenus Inc. over the last ten years is 2.09. The current 0.37 Current Ratio has changed 1.67% with respect to the historical average. Over the past ten years (40 quarters), AGEN's Current Ratio was at its highest in in the September 2015 quarter at 7.39. The Current Ratio was at its lowest in in the March 2024 quarter at 0.24.
Average
2.09
Median
1.22
Minimum
0.44
Maximum
6.36
Discovering the peaks and valleys of Agenus Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 141.46%
Maximum Annual Current Ratio = 6.36
Minimum Annual Increase = -64.87%
Minimum Annual Current Ratio = 0.44
Year | Current Ratio | Change |
---|---|---|
2023 | 0.44 | -61.05% |
2022 | 1.13 | -46.68% |
2021 | 2.12 | 141.46% |
2020 | 0.88 | 23.72% |
2019 | 0.71 | -35.58% |
2018 | 1.10 | -15.66% |
2017 | 1.30 | -41.69% |
2016 | 2.24 | -64.87% |
2015 | 6.36 | 37.62% |
2014 | 4.62 | 68.95% |
The current Current Ratio of Agenus Inc. (AGEN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
1.23
5-year avg
1.05
10-year avg
2.09
Agenus Inc.’s Current Ratio is less than Icosavax, Inc. (18.06), less than Galera Therapeutics, Inc. (5.63), less than Marker Therapeutics, Inc. (5.92), less than Edgewise Therapeutics, Inc. (30.24), less than Adaptimmune Therapeutics plc (3.09), less than Mereo BioPharma Group plc (6.07), less than Pieris Pharmaceuticals, Inc. (3.95), less than PDS Biotechnology Corporation (3.84), less than Leap Therapeutics, Inc. (5.10), less than Viking Therapeutics, Inc. (37.69), less than TG Therapeutics, Inc. (3.58), less than X4 Pharmaceuticals, Inc. (6.07), less than Madrigal Pharmaceuticals, Inc. (8.72), less than TCR2 Therapeutics Inc. (2.96), less than Affimed N.V. (2.71), less than ADC Therapeutics SA (6.17),
Company | Current Ratio | Market cap |
---|---|---|
18.06 | $769.04M | |
5.63 | $4.08M | |
5.92 | $26.59M | |
30.24 | $1.64B | |
3.09 | $278.72M | |
6.07 | $664.26M | |
3.95 | $22.50M | |
3.84 | $107.88M | |
5.10 | $107.52M | |
37.69 | $6.00B | |
3.58 | $3.41B | |
6.07 | $109.78M | |
8.72 | $5.30B | |
2.96 | $58.11M | |
2.71 | $57.26M | |
6.17 | $260.95M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Agenus Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Agenus Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Agenus Inc.'s Current Ratio?
How is the Current Ratio calculated for Agenus Inc. (AGEN)?
What is the highest Current Ratio for Agenus Inc. (AGEN)?
What is the 3-year average Current Ratio for Agenus Inc. (AGEN)?
What is the 5-year average Current Ratio for Agenus Inc. (AGEN)?
How does the current Current Ratio for Agenus Inc. (AGEN) compare to its historical average?